ArticleClinical drug investigation2017

Cost-Effectiveness Analysis of Regorafenib for Gastrointestinal Stromal Tumour (GIST) in Germany.

David Tamoschus et al.PubMed ↗Publisher ↗

No numbers read from the abstract.